Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

T-Therapeutics secures $133M for cancer, autoimmune TCRs

Johnson & Johnson, Merck KGaA and Eli Lilly are joining Sanofi in backing a UK biotech working on T cell receptors for autoimmune conditions and cancer. The pharma companies or their corporate ...

We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.

Read the original at endpoints.news →

More in Health & Medicine

More from Thursday 5 November →